ArticleACS omega2026
Photo-Cross-Linked Pluronic F127 Hydrogels for Controlled Protein Delivery.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hydrogels are promising platforms for controlled delivery of biomacromolecules due to their biocompatibility, water retention, and similarity to the extracellular matrix, which supports cell interaction and tissue integration. This study presents the development and characterization of diacrylated Pluronic F127-based hydrogels for biomedical applications, focusing on controlled protein release. Bovine serum albumin (BSA) was used as a model protein to assess release behavior under varying physiological conditions. The hydrogels were synthesized via photopolymerization, and their structural integrity, swelling capacity, and stability were analyzed. Release assays under different pH levels and BSA concentrations showed that both factors significantly affected the release profile. Depending on these conditions, the release followed either a first-order or biphasic pattern, indicating both diffusion- and matrix-driven mechanisms. This tunability highlights the system's adaptability for specific therapeutic needs requiring precise temporal protein delivery. Physicochemical analyses and kinetic modeling confirmed that release behavior can be tailored through environmental and formulation parameters. These findings demonstrate the potential of Pluronic F127 hydrogels as versatile, customizable platforms for localized therapeutic protein delivery, with broad implications in regenerative medicine, targeted drug delivery, and other biomedical fields.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.